Eurazeo Shares Drop 2.5% and Slip Below Its MM20, Weighed Down by Wall Street
The Parisian asset manager significantly retreats as the market closes, in a Parisian market heavily shaken by the resurgence of tensions in the Middle East. The stock erases its early-week surge and drifts further away from its technical benchmarks.
A Decline that Widens the Gap with Medium-Term Moving Averages
Eurazeo shares drop 2.5% to €40.60, in a CAC 40 down by 2% and an SBF 120 that retreats by 1.95%. The market context is burdened by a new escalation between Washington and Tehran, with Donald Trump stating from Ankara that the ceasefire with Iran was over, in his view. The session erases the stock's slight weekly gain (+1.5% over seven days), without reversing the monthly decline that now reaches nearly 7%.
The price moves below its MM20 (€41.93) with a gap of 3.17%, and remains distant from its MM50 (€44.54, gap of 8.85%) as well as its MM200 (€49.55, gap of 18.06%). The RSI at 43 indicates a lackluster momentum, without extremes. The support at €39.92 becomes the next technical level monitored, as monthly volatility climbs to 9.37% and the VIX jumps by more than 12% to 18.14.
A Dense Corporate News Flow Contrasts with the Day's Decline
The stock falls while recent company announcements align with its roadmap. The group completed the closing of its fifth secondary program on July 6 at €2.3 billion, exceeding the initial target of €2 billion and well above the €1 billion raised in 2021 for the previous vintage. A few days earlier, the group had sold its Spanish hotel portfolio FST to Extendam for approximately €100 million, while Kurma Partners announced the sale of Memo Therapeutics to Ipsen for a potential consideration exceeding €700 million.
During the Q1 2026 publication (on May 13, 2026), the company highlighted a 17% increase in deployments and the achievement of an Investment Grade rating by S&P and Fitch, while confirming the ramp-up of its model. Over twelve months, however, the stock shows a decline of 30.48% and trades more than 18% below its 200-day moving average. The support at €39.92 remains the key technical level at the end of the session.
